Home › Endocrine Diseases › Washington
Endocrine Diseases clinical trials in Washington
4 studies for Endocrine Diseases are looking for participants at sites in Washington.
Cities in Washington
Trial Investigating the Efficacy and Safety of Weekly Lonapegsomatropin Compared to Daily Somatropin in Children and Adolescents With Short Stature or Growth Failure Due to Growth Hormone Sufficient Disorders
- Ascendis Pharma Investigational Site, Seattle
RecruitingPhase 3
Ages 2 to 17 · All sexes · Updated Sep 29, 2026 · NCT07221851METabolic MODulation to Enhance Insulin Sensitivity and Mitochondrial Function in Type 1 Diabetes (MetMod-T1D)
- University of Washington Medicine Diabetes Institute (UWMDI), Seattle
RecruitingPhase 2
Ages 18 to 69 · All sexes · Updated Sep 15, 2026 · NCT07699380A Phase 3 Randomized Clinical Trial to Investigate the Safety and Efficacy of Palopegteriparatide at Doses Greater Than 30 μg/Day in Adult Participants With Hypoparathyroidism
- Ascendis Pharma Investigational Site, Spokane Valley
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Aug 24, 2026 · NCT07081997Rare and Atypical Diabetes Network
- University of Washington, Seattle
RecruitingObservational study
All ages · All sexes · Updated Aug 14, 2025 · NCT05544266From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.